Cargando…
Comparison of antiangina therapies in patients with coronary heart disease in China: study protocol for a multicentre, retrospective, hospital system-based study
INTRODUCTION: China has the largest number of patients with coronary heart disease (CHD) in the world. Numerous pharmacological strategies are available for CHD in routine clinical practice. CHD-induced angina pectoris affects patients’ quality of life and is a key predictor of prognosis. This study...
Autores principales: | Li, Ping, Chen, Juan, Ke, Zheng, Han, Jing, Shen, Lan, Zhou, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925860/ https://www.ncbi.nlm.nih.gov/pubmed/33550222 http://dx.doi.org/10.1136/bmjopen-2020-036954 |
Ejemplares similares
-
Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) retrospective study of coronary catheterisation and percutaneous coronary intervention
por: Li, Jing, et al.
Publicado: (2014) -
Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial
por: Huang, Zhuoshan, et al.
Publicado: (2023) -
Impact of metoprolol standard dosing pathway in Chinese patients with acute coronary syndrome: protocol for a multicentre prospective study
por: Li, Dandan, et al.
Publicado: (2019) -
Measuring outcome differences associated with STEMI screening and diagnostic performance: a multicentred retrospective cohort study protocol
por: Yiadom, Maame Yaa A B, et al.
Publicado: (2018) -
Efficacy and safety of Ginkgo biloba dropping pills in the treatment of coronary heart disease with stable angina pectoris and depression: study protocol for a randomised, placebo-controlled, parallel-group, double-blind and multicentre clinical trial
por: Wu, Tingchun, et al.
Publicado: (2023)